Understanding Niacins Role In Your Cardiovascular Care

New studies question niacins role in reducing the risk of cardiovascular disease, yet it may still be effective for some, says a Cleveland Clinic expert.

Niacin, also known as vitamin B3, became popular more than 30 years ago when the Coronary Drug Project trial, which looked at 8,341 patients after heart attack, suggested the possibility that the drug might reduce the risk of recurrent heart disease. From that point forward, niacin has been the hope for elevating the good (HDL) while assisting the decrease in the bad (LDL) cholesterol levels.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access


Please enter your comment!
Please enter your name here